OBJECTIVE: To describe the theoretical principles that guided the establishment of Project Eban's Community Advisory Boards (CABs), their functions, and composition; the selection and recruitment processes; lessons learned; and recommendations on the use of CABs in multisite HIV clinical trial studies. METHODS: In the first year of Project Eban's implementation, each of the 4 sites formed a local CAB. Member recruitment took place during the first 6 months of the study. On average, each site's CAB consisted of 13-19 stakeholders, with a total of 62 members for the multisite study, including leaders of HIV/AIDS-related community-based organizations (CBOs), hospital-based HIV/AIDS service providers, HIV/AIDS network leaders in minority communities, CBOs that serve predominantly black communities, and consumers. RESULTS: Each of the CAB members has expressed a strong commitment to assisting in the conduct of the research. CABs are integral to the success of the study, and their input is highly respected and used to improve the quality of the research. CONCLUSIONS: This article highlights the importance of CABs in the conduct of HIV multisite clinical trials and their roles in making the study culturally congruent to meet the needs of the black community in dealing with the HIV epidemic.
OBJECTIVE: To describe the theoretical principles that guided the establishment of Project Eban's Community Advisory Boards (CABs), their functions, and composition; the selection and recruitment processes; lessons learned; and recommendations on the use of CABs in multisite HIV clinical trial studies. METHODS: In the first year of Project Eban's implementation, each of the 4 sites formed a local CAB. Member recruitment took place during the first 6 months of the study. On average, each site's CAB consisted of 13-19 stakeholders, with a total of 62 members for the multisite study, including leaders of HIV/AIDS-related community-based organizations (CBOs), hospital-based HIV/AIDS service providers, HIV/AIDS network leaders in minority communities, CBOs that serve predominantly black communities, and consumers. RESULTS: Each of the CAB members has expressed a strong commitment to assisting in the conduct of the research. CABs are integral to the success of the study, and their input is highly respected and used to improve the quality of the research. CONCLUSIONS: This article highlights the importance of CABs in the conduct of HIV multisite clinical trials and their roles in making the study culturally congruent to meet the needs of the black community in dealing with the HIV epidemic.
Authors: A McCormick; M M McKay; M Wilson; L McKinney; R Paikoff; C Bell; D Baptiste; D Coleman; G Gillming; S Madison; R Scott Journal: AIDS Educ Prev Date: 2000-08
Authors: Cami K McBride; Donna Baptiste; Dorian Traube; Roberta L Paikoff; Sybil Madison-Boyd; Doris Coleman; Carl C Bell; Ida Coleman; Mary M McKay Journal: Soc Work Ment Health Date: 2007-05-01
Authors: Donna R Baptiste; Arvin Bhana; Inge Petersen; Mary McKay; Dexter Voisin; Carl Bell; Dona D Martinez Journal: J Pediatr Psychol Date: 2006-02-01
Authors: R P Strauss; S Sengupta; S C Quinn; J Goeppinger; C Spaulding; S M Kegeles; G Millett Journal: Am J Public Health Date: 2001-12 Impact factor: 9.308
Authors: S Galea; S H Factor; S Bonner; M Foley; N Freudenberg; M Latka; A G Palermo; D Vlahov Journal: Public Health Rep Date: 2001 Nov-Dec Impact factor: 2.792
Authors: Benjamin Kaplan; Carolyn Caddle-Steele; Gregory Chisholm; Warria A Esmond; Kadija Ferryman; Melvin Gertner; Crispin Goytia; Diane Hauser; Lynne D Richardson; Mimsie Robinson; Carol R Horowitz Journal: Prog Community Health Partnersh Date: 2017
Authors: Charles Muiruri; Chris T Longenecker; Eric G Meissner; Nwora Lance Okeke; April C Pettit; Kevin Thomas; Eric Velazquez; Gerald S Bloomfield Journal: Prog Cardiovasc Dis Date: 2020-02-11 Impact factor: 8.194
Authors: Jenny K R Francis; Lily F Hoffman; Mei-Chen Hu; Ariel M de Roche; Marina Catallozzi; Carmen Radecki Breitkopf; Susan L Rosenthal Journal: J Pediatr Adolesc Gynecol Date: 2015-09-25 Impact factor: 1.814